Efficacy and tolerability of peginterferon alfa-2a (40kd) and ribavirin in genotype 4 patients with chronic hepatitis C (CHC) under real life conditions

被引：0

作者：

Zehnter, E. ^{[1
]}

Mauss, S. ^{[18
]}

Kaiser, S. ^{[2
]}

Boeker, K. ^{[3
]}

Lutz, T. ^{[4
]}

Heyne, R. ^{[5
]}

John, C. ^{[6
]}

Moog, G. ^{[7
]}

Schober, A. ^{[8
]}

Pfaff, R. ^{[9
]}

Zipf, A. ^{[10
]}

Racky, S. ^{[11
]}

Lohmeyer, J. ^{[12
]}

Bokemeyer, B. ^{[13
]}

Kallinowski, B. ^{[14
]}

Witthoeft, T. ^{[15
]}

Alshuth, U. ^{[16
]}

Hueppe, D. ^{[17
]}

机构：

[1] Ctr Gastroenterol, Dortmund, Germany

[2] Klinikum Eberhard Karls Univ, Tubingen, Germany

[3] Ctr Gastroenterol, Hannover, Germany

[4] Infektiologikum, Frankfurt, Germany

[5] Ctr Gastroenterol & Liver Ctr, Berlin, Germany

[6] Ctr Gastroenterol, Berlin, Germany

[7] Ctr Gastroenterol, Kassel, Germany

[8] Ctr Gastroenterol, Gottingen, Germany

[9] Ctr Gastroenterol, Giessen, Germany

[10] Ctr Gastroenterol, Mannheim, Germany

[11] Ctr Gastroenterol, Bad Schwalbach, Germany

[12] Univ Giessen, Giessen, Germany

[13] Ctr Gastroenterol, Minden, Germany

[14] Ctr Gastroenterol, Schwetzingen, Germany

[15] Univ Hosp Schleswig Holstein, Div Gastroenterol, Dept Med 1, Lubeck, Germany

[16] Roche Pharma AG, BU Hepatitis HIV CF, Grenzach Wyhlen, Germany

[17] Ctr Gastroenterol, Herne, Germany

[18] Ctr HIV & Hepatogastrenterol, Dusseldorf, Germany

来源：

JOURNAL OF HEPATOLOGY | 2008年 / 48卷

关键词：

D O I：

10.1016/S0168-8278(08)60844-2

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

842

引用

页码：S316 / S316

页数：1

共 50 条

[1] Efficacy and tolerability of peginterferom alfa-2a (40KD) and ribavirin in genotype 4 patients with chronic hepatitis C (cHC) under real life conditions
Zehnter, Elmar
Mauss, Stefan
Hueppe, Dietrich
Kaiser, Stephan
Boeker, Klaus
Lutz, Thomas
Heyne, Renate
John, Christine
Moog, Gero
Schober, Andreas
Pfaff, Rainer
Zipf, Andreas
Racky, Stefan A.
Lohmeyer, Jueregn
Bokemeyer, Bernd
Kallinowski, Birgit
Witthoeft, Thomas
Alshuth, Ulrich
GASTROENTEROLOGY, 2008, 134 (04) : A831 - A831
[2] Efficacy and Tolerability of Peginterferon Alfa-2a (40KD) (PEG) and Ribavirin (RBV) in Genotype 5 and 6 Patients with Chronic Hepatitis C Under Real Life Conditions
Hueppe, Dietrich
Zehnter, Elmar
Mauss, Stefan
Kaiser, Stephan
Schober, Andreas
Schuchmann, Marcus
Boeker, Klaus
Moog, Gero
Schiffelholz, Willibold
Pape, Stefan
Heyne, Renate
Ackermann, Frank
Schmidt, Wolfgang
John, Christine
Lohmeyer, Juergen
Hey, Karl-Heinz
Alshuth, Ulrich
GASTROENTEROLOGY, 2009, 136 (05) : A839 - A840
[3] Predictive factors in treatment of chronic hepatitis c (cHC) patients with peginterferon alfa-2a (40KD) and ribavirin
Zehnter, Elmar
Mauss, Stefan
John, Christine
Heyne, Renate
Moeller, Berrid
Lutz, Thomas
Bokemeyer, Bernd
Kihn, Robert
Moog, Gero
Vornkahl, Heike
Alshuth, Ulrich
Hueppe, Dietrich
GASTROENTEROLOGY, 2006, 130 (04) : A839 - A839
[4] PREDICTIVE FACTORS OF THROMBOCYTOPENIA IN TREATMENT OF CHRONIC HEPATITIS C (CHC) PATIENTS WITH PEGINTERFERON ALFA-2A (40KD) AND RIBAVIRIN
Mauss, S.
Schober, A.
Lutz, T.
Moog, G.
Schuchmann, M.
Heyne, R.
John, C.
Schiffelholz, W.
Baumgarten, A.
Hey, K. -H.
Eisenbach, C.
Teuber, G.
Schmidt, W.
Bruch, H. -R.
Geyer, P.
Alshuth, U.
Hueppe, D.
JOURNAL OF HEPATOLOGY, 2011, 54 : S185 - S185
[5] Predictive Factors of Thrombocytopenia in Treatment of Chronic Hepatitis C (CHC) Patients With Peginterferon Alfa-2a (40KD) and Ribavirin
Mauss, Stefan
Schober, Andreas
Lutz, Thomas
Moog, Gero
Schuchmann, Marcus
Heyne, Renate
John, Christine
Schiffelholz, Willibold
Baumgarten, Axel
Hey, Karl-Heinz
Eisenbach, Christoph
Teuber, Gerlinde
Schmidt, Wolfgang
Bruch, Harald-Robert
Geyer, Peter
Alshuth, Ulrich
Hueppe, Dietrich
GASTROENTEROLOGY, 2011, 140 (05) : S948 - S948
[6] Safety and adherence to peginterferon alfa-2a (40KD) plus ribavirin (RBV) in black Americans with chronic hepatitis C (CHC) HCV genotype 1
Howell, CD
Jeffers, LS
Hu, S
Lopez-Talavera, JC
GASTROENTEROLOGY, 2004, 126 (04) : A722 - A723
[7] Efficacy of peginterferon alfa-2a (40KD) and ribavirin in patients with chronic hepatitis C in Germany -: A contribution to health care research
Zehnter, E
Mauss, S
John, C
Heyne, R
Möller, B
Bokemeyer, B
Moog, G
Alshuth, U
Hüppe, D
HEPATOLOGY, 2005, 42 (04) : 683A - 683A
[8] Treatment of chronic hepatitis C with peginterferon alfa-2a (40KD) and ribavirin in patients with or without drug use
Zehnter, Elmar
Mauss, Stefan
John, Christine
Heyne, Renate
Moeller, Bernd
Lutz, Thomas
Bokemeyer, Bernd
Kihn, Robert
Moog, Gero
Vornkahl, Heike
Alshuth, Ulrich
Hueppe, Dietrich
GASTROENTEROLOGY, 2006, 130 (04) : A840 - A840
[9] Treatment of chronic hepatitis C (cHC) with peginterferon Alfa-2a (40KD) (PEG) and ribavirin (RBV) in patients older than 60 years
Meyer, Ulrike
Zehnter, Elmar
Mauss, Stefan
Boeker, Klaus
Lutz, Thomas
Racky, Stefan
Schmidt, Wolfgang
Ullrich, Rainer
Sbrijer, Innessa
Heyne, Renate
Schober, Andreas
John, Christine
Hey, Karl-Heinz
Bokemeyer, Bernd
Kallinowski, Birgit
Moeller, Bernd
Pape, Stefan
Alshuth, Ulrich
Hueppe, Dietrich
GASTROENTEROLOGY, 2007, 132 (04) : A790 - A791
[10] Balapiravir plus peginterferon alfa-2a (40KD)/ribavirin in a randomized trial of hepatitis C genotype 1 patients
Nelson, David R.
Zeuzem, Stefan
Andreone, Pietro
Ferenci, Peter
Herring, Robert
Jensen, Donald M.
Marcellin, Patrick
Pockros, Paul J.
Rodriguez-Torres, Maribel
Rossaro, Lorenzo
Rustgi, Vinod K.
Sepe, Thomas
Sulkowski, Mark
Thomason, Isaac R.
Yoshida, Eric M.
Chan, Anna
Hill, George
ANNALS OF HEPATOLOGY, 2012, 11 (01) : 15 - 31

← 1 2 3 4 5 →